Pharmaceuticals

Global SNP Genotyping And Analysis Market Size Projected to Reach $38.58 Billion During the Forecast Period

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The SNP Genotyping And Analysis Market Over The Five-Year Period 2025–2029?

The SNP genotyping and analysis market has observed rapid expansion in recent years. It is anticipated to expand from $15.45 billion in 2024 to $18.5 billion in 2025, recording a compound annual growth rate (CAGR) of 19.7%. The growth witnessed historically is primarily a result of increasing biomedical research funding, the broadening of personalized medicine initiatives, the surge in agricultural genomics, the substantial impact of chronic diseases, and the introduction of commercial genomic services.

The SNP genotyping and analysis market size is anticipated to experience substantial growth over the next few years. It is projected to reach $38.58 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 20.2%. This expansion during the forecast period can be attributed to the increasing number of population genomics projects, a greater focus on diagnosing rare diseases, developments in companion diagnostics and precision oncology, the rising demand for direct-to-consumer (DTC) genomics, and supportive regulatory policies for genomic medicine. Significant trends expected during this period include technological innovations in genotyping platforms, the integration of artificial intelligence and bioinformatics, further expansion in oncology research, increased adoption in forensic and ancestry testing, and the development of portable genotyping devices.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24402&type=smp

Which Drivers Are Shaping The SNP Genotyping And Analysis Industry’s Market Share?

The increasing prevalence of genetic conditions is anticipated to fuel expansion in the SNP genotyping and analysis market moving ahead. These are medical disorders resulting from irregularities in an individual’s DNA, potentially inherited from either parent or emerging from mutations during cell division. This burden is escalating due to heightened awareness and advancements in diagnostic tools, which have led to a greater number of diagnoses and better identification of genetic disorders. SNP genotyping and analysis assist in addressing genetic diseases by pinpointing genetic variations linked to disease risk, progression, and medication response, thereby enabling early diagnosis and personalized treatment. For instance, a report from Cystic Fibrosis Australia, an Australia-based national body for people living with cystic fibrosis, released in February 2024, indicated that the count of people living with cystic fibrosis in Australia had climbed to 3,738 by 2022, an increase from 3,616 cases reported in 2021. Consequently, the rising impact of genetic diseases is driving the growth of the SNP genotyping and analysis market.

How Is The SNP Genotyping And Analysis Market Segmented?

The snp genotyping and analysis market covered in this report is segmented –

1) By Sample Type: Genomic DNA, Ribonucleic Acid (RNA), Cell-Free DNA (cfDNA), Plasma Samples, Whole Blood

2) By Technology: Microarrays And GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex, Sequemon MassArray Maldi-TOF, Other Technologies

3) By Application: Disease Diagnostics, Pharmacogenomics, Precision Medicine, Forensic Science, Agriculture And Livestock

4) By End User: Hospitals And Clinics, Research Laboratories, Pharmaceutical And Biotechnological Companies, Diagnostic Laboratories, Academic And Government Institutions

Subsegments:

1) By Genomic DNA: Whole Genome Sequencing (WGS), Targeted Sequencing, Microarrays

2) By Ribonucleic Acid (RNA): RNA-Seq, Expression Profiling, Microarrays

3) By Cell-Free DNA (cfDNA): Liquid Biopsy, Non-Invasive Prenatal Testing (NIPT), Oncology Research

4) By Plasma Samples: Circulating Tumor DNA (ctDNA), Liquid Biopsy Applications, Diagnostics

5) By Whole Blood: DNA Extraction And Analysis, Blood-Based Genomic Studies, Genotyping And Molecular Diagnostics

Which Ongoing Trends Are Expected To Shape The SNP Genotyping And Analysis Market Outlook?

Key players in the SNP genotyping and analysis market are concentrating on developing technologically advanced solutions, such as agricultural large-scale low-pass whole genome sequencing, to address significant challenges in molecular breeding genotyping of agricultural diploid species. Agricultural whole genome sequencing involves decoding the complete genetic material of crops or livestock to enhance traits like yield, disease resistance, and environmental adaptability. For instance, in June 2024, MGI Tech, a China-based biotechnology company, introduced a highly efficient whole workflow solution for agricultural large-scale low-pass whole genome sequencing (low-pass WGS). This solution features an automated full-process product portfolio covering DNA extraction, library preparation, sequencing, and SNP & InDel calling, specifically designed for molecular breeding genotyping of agricultural diploid species. It incorporates advanced automation platforms and utilizes MGI’s DNBSEQ-T7 and DNBSEQ-G400 sequencers to achieve ultra-high throughput and flexibility. The workflow also includes pig reference panels and data analysis software to streamline genotyping without requiring custom database creation.

Which Global Market Leaders Are Shaping The Future Of The SNP Genotyping And Analysis Sector?

Major companies operating in the SNP genotyping and analysis market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Eurofins Genomics Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Life Sciences Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., Azenta Life Sciences Inc., LGC Limited, Invitae Corporation, Oxford Nanopore Technologies Limited, Standard BioTools Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Sophia Genetics SA, Genedata AG, Genotypic Technology Private Limited, PREMIER Biosoft International

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/snp-genotyping-and-analysis-global-market-report

What Are The Key Regional Factors Influencing The SNP Genotyping And Analysis Market Growth?

North America was the largest region in the SNP genotyping and analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the SNP genotyping and analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The SNP Genotyping And Analysis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24402&type=smp

Browse Through More Reports Similar to the Global SNP Genotyping And Analysis Market 2025, By The Business Research Company

Single Nucleotide Polymorphism Snp Genotyping Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/single-nucleotide-polymorphism-snp-genotyping-global-market-report

Genotyping Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report

Genotyping Assay Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795